JP2006503057A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006503057A5 JP2006503057A5 JP2004537831A JP2004537831A JP2006503057A5 JP 2006503057 A5 JP2006503057 A5 JP 2006503057A5 JP 2004537831 A JP2004537831 A JP 2004537831A JP 2004537831 A JP2004537831 A JP 2004537831A JP 2006503057 A5 JP2006503057 A5 JP 2006503057A5
- Authority
- JP
- Japan
- Prior art keywords
- carbonitrile
- glycyl
- pyrrolidine
- ethynyl
- ethynylpyrrolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 2-indolinyl Chemical group 0.000 claims 57
- 150000001875 compounds Chemical class 0.000 claims 33
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 31
- 125000000217 alkyl group Chemical group 0.000 claims 27
- 229910052739 hydrogen Inorganic materials 0.000 claims 19
- 239000001257 hydrogen Substances 0.000 claims 19
- ALSCEGDXFJIYES-UHFFFAOYSA-N pyrrolidine-2-carbonitrile Chemical compound N#CC1CCCN1 ALSCEGDXFJIYES-UHFFFAOYSA-N 0.000 claims 19
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 17
- 125000004093 cyano group Chemical group *C#N 0.000 claims 16
- 125000003342 alkenyl group Chemical group 0.000 claims 15
- 125000000304 alkynyl group Chemical group 0.000 claims 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 12
- 125000000623 heterocyclic group Chemical group 0.000 claims 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims 7
- 150000002431 hydrogen Chemical class 0.000 claims 7
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 5
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 3
- 125000005343 heterocyclic alkyl group Chemical group 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- WLGYZHSSENEZRE-AVGNSLFASA-N (2s,5r)-1-[(2s)-2-amino-2-cyclopentylacetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1([C@H](N)C(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCCC1 WLGYZHSSENEZRE-AVGNSLFASA-N 0.000 claims 2
- XXTBOOXAFXMJIZ-SRVKXCTJSA-N (2s,5r)-1-[(2s)-2-amino-4-methylpentanoyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound CC(C)C[C@H](N)C(=O)N1[C@@H](C#C)CC[C@H]1C#N XXTBOOXAFXMJIZ-SRVKXCTJSA-N 0.000 claims 2
- QNJHRRHEUUPUFK-IRDVNMAFSA-N (2s,5r)-5-ethynyl-1-[2-[[1-methyl-4-[5-(trifluoromethyl)pyridin-2-yl]oxycyclohexyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCC1OC1=CC=C(C(F)(F)F)C=N1 QNJHRRHEUUPUFK-IRDVNMAFSA-N 0.000 claims 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 125000005282 allenyl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- GWVRCGAFLKJTEN-AIHGNGHHSA-N (2S,5S)-5-methyl-1-[2-[[(1S,5R)-3-tricyclo[3.3.1.03,7]nonanyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C([C@]1(CC2C[C@@](C3)(C1)[H])[H])C23NCC(=O)N1[C@@H](C)CC[C@H]1C#N GWVRCGAFLKJTEN-AIHGNGHHSA-N 0.000 claims 1
- FRGISDJQXAKTDV-MELADBBJSA-N (2s,5r)-1-[(2r)-2-amino-2-cyclohexylacetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1([C@@H](N)C(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCCCC1 FRGISDJQXAKTDV-MELADBBJSA-N 0.000 claims 1
- SOGGVAAJATVSRA-RWMBFGLXSA-N (2s,5r)-1-[(2r)-2-amino-2-cyclopentylacetyl]-5-ethenylpyrrolidine-2-carbonitrile Chemical compound C1([C@@H](N)C(=O)N2[C@@H](CC[C@@H]2C=C)C#N)CCCC1 SOGGVAAJATVSRA-RWMBFGLXSA-N 0.000 claims 1
- ADOYZNNVXXDNOW-IHRRRGAJSA-N (2s,5r)-1-[(2s)-2-amino-2-cyclohexylacetyl]-5-ethenylpyrrolidine-2-carbonitrile Chemical compound C1([C@H](N)C(=O)N2[C@@H](CC[C@@H]2C=C)C#N)CCCCC1 ADOYZNNVXXDNOW-IHRRRGAJSA-N 0.000 claims 1
- FRGISDJQXAKTDV-IHRRRGAJSA-N (2s,5r)-1-[(2s)-2-amino-2-cyclohexylacetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1([C@H](N)C(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCCCC1 FRGISDJQXAKTDV-IHRRRGAJSA-N 0.000 claims 1
- SOGGVAAJATVSRA-AVGNSLFASA-N (2s,5r)-1-[(2s)-2-amino-2-cyclopentylacetyl]-5-ethenylpyrrolidine-2-carbonitrile Chemical compound C1([C@H](N)C(=O)N2[C@@H](CC[C@@H]2C=C)C#N)CCCC1 SOGGVAAJATVSRA-AVGNSLFASA-N 0.000 claims 1
- XMYBPHZGYQEJKQ-XSXXDBAGSA-N (2s,5r)-1-[2-(1-adamantylamino)acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1C(C2)CC(C3)CC2CC13NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N XMYBPHZGYQEJKQ-XSXXDBAGSA-N 0.000 claims 1
- CGPXQFKYXWWTLB-RYUDHWBXSA-N (2s,5r)-1-[2-(cyclobutylamino)acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CCC1 CGPXQFKYXWWTLB-RYUDHWBXSA-N 0.000 claims 1
- HDKGJFXDNVUINF-GJZGRUSLSA-N (2s,5r)-1-[2-(cycloheptylamino)acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CCCCCC1 HDKGJFXDNVUINF-GJZGRUSLSA-N 0.000 claims 1
- GFCJINGFBXPTAG-KBPBESRZSA-N (2s,5r)-1-[2-(cyclohexylamino)acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CCCCC1 GFCJINGFBXPTAG-KBPBESRZSA-N 0.000 claims 1
- PAOXGRAINLIPSS-STQMWFEESA-N (2s,5r)-1-[2-(cyclopentylamino)acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CCCC1 PAOXGRAINLIPSS-STQMWFEESA-N 0.000 claims 1
- VBQFUZRGSACCBZ-QWRGUYRKSA-N (2s,5r)-1-[2-(cyclopropylamino)acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CC1 VBQFUZRGSACCBZ-QWRGUYRKSA-N 0.000 claims 1
- AYFKPVVQCFNFFY-QWRGUYRKSA-N (2s,5r)-1-[2-(tert-butylamino)acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound CC(C)(C)NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N AYFKPVVQCFNFFY-QWRGUYRKSA-N 0.000 claims 1
- VSYGRYMDJJHFTC-STQMWFEESA-N (2s,5r)-1-[2-[2-[[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino]ethylamino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound ClC1=CC(C(F)(F)F)=CN=C1NCCNCC(=O)N1[C@H](C#N)CC[C@@H]1C#C VSYGRYMDJJHFTC-STQMWFEESA-N 0.000 claims 1
- ZCBKMVXYSNNRAE-AIEDFZFUSA-N (2s,5r)-1-[2-[[(1s,3r,4r)-3-bicyclo[2.2.1]heptanyl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N([C@H]1[C@]2([H])CC[C@@](C2)(C1)[H])CC(=O)N1[C@@H](C#C)CC[C@H]1C#N ZCBKMVXYSNNRAE-AIEDFZFUSA-N 0.000 claims 1
- ZCBKMVXYSNNRAE-UZSCSNNJSA-N (2s,5r)-1-[2-[[(1s,4r)-3-bicyclo[2.2.1]heptanyl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1([C@]2([H])CC[C@@](C2)(C1)[H])NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N ZCBKMVXYSNNRAE-UZSCSNNJSA-N 0.000 claims 1
- CJLKZSAZEFHUPQ-GJZGRUSLSA-N (2s,5r)-1-[2-[[1-(1,3-benzothiazol-2-ylamino)-2-methylpropan-2-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N=1C2=CC=CC=C2SC=1NCC(C)(C)NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N CJLKZSAZEFHUPQ-GJZGRUSLSA-N 0.000 claims 1
- LXKFPJQGEJYBIP-IRXDYDNUSA-N (2s,5r)-1-[2-[[1-(2-cyano-5-fluorophenoxy)-2-methylpropan-2-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)COC1=CC(F)=CC=C1C#N LXKFPJQGEJYBIP-IRXDYDNUSA-N 0.000 claims 1
- ZTYLMFRQXAVJLT-ICSRJNTNSA-N (2s,5r)-1-[2-[[1-(3-cyanophenyl)-4-methylpiperidin-4-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CC=CC(C#N)=C1 ZTYLMFRQXAVJLT-ICSRJNTNSA-N 0.000 claims 1
- AOBLBPOOAASJAY-OALUTQOASA-N (2s,5r)-1-[2-[[1-(4-bromobenzoyl)-4-methylpiperidin-4-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C(=O)C1=CC=C(Br)C=C1 AOBLBPOOAASJAY-OALUTQOASA-N 0.000 claims 1
- WCQXAVDREAIDAV-OALUTQOASA-N (2s,5r)-1-[2-[[1-(4-chlorobenzoyl)-4-methylpiperidin-4-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C(=O)C1=CC=C(Cl)C=C1 WCQXAVDREAIDAV-OALUTQOASA-N 0.000 claims 1
- LFRXAAGPLSHLOR-OALUTQOASA-N (2s,5r)-1-[2-[[1-(4-chlorobenzoyl)piperidin-4-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1=CC(Cl)=CC=C1C(=O)N1CCC(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CC1 LFRXAAGPLSHLOR-OALUTQOASA-N 0.000 claims 1
- PEAHDBDUWWSDHW-PMACEKPBSA-N (2s,5r)-1-[2-[[1-(4-cyanobenzoyl)-4-methylpiperidin-4-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C(=O)C1=CC=C(C#N)C=C1 PEAHDBDUWWSDHW-PMACEKPBSA-N 0.000 claims 1
- VLAPRGLPYLXNQC-IRXDYDNUSA-N (2s,5r)-1-[2-[[1-(5-chloropyridin-2-yl)-4-methylpiperidin-4-yl]amino]acetyl]-5-ethynylpyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CC=C(Cl)C=N1 VLAPRGLPYLXNQC-IRXDYDNUSA-N 0.000 claims 1
- OUKUHZKNGLRGRJ-JYJNAYRXSA-N (2s,5r)-5-ethynyl-1-[(3s)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl]pyrrolidine-2-carbonitrile Chemical compound O=C([C@H]1NCC2=CC=CC=C2C1)N1[C@@H](C#C)CC[C@H]1C#N OUKUHZKNGLRGRJ-JYJNAYRXSA-N 0.000 claims 1
- NAMRVSAUNWIJNM-KBPBESRZSA-N (2s,5r)-5-ethynyl-1-[2-(2,4,4-trimethylpentan-2-ylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound CC(C)(C)CC(C)(C)NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N NAMRVSAUNWIJNM-KBPBESRZSA-N 0.000 claims 1
- NRGHIGFZYSBLQJ-RYUDHWBXSA-N (2s,5r)-5-ethynyl-1-[2-(2-methylbutan-2-ylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound CCC(C)(C)NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N NRGHIGFZYSBLQJ-RYUDHWBXSA-N 0.000 claims 1
- ABHKYJSXPJZTAN-GJZGRUSLSA-N (2s,5r)-5-ethynyl-1-[2-(2-pyridin-4-ylethylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNCCC1=CC=NC=C1 ABHKYJSXPJZTAN-GJZGRUSLSA-N 0.000 claims 1
- ZUMRJPNZDXLRTC-KBPBESRZSA-N (2s,5r)-5-ethynyl-1-[2-(3-propan-2-yloxypropylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound CC(C)OCCCNCC(=O)N1[C@@H](C#C)CC[C@H]1C#N ZUMRJPNZDXLRTC-KBPBESRZSA-N 0.000 claims 1
- UIMBZPRWYBAKNN-STQMWFEESA-N (2s,5r)-5-ethynyl-1-[2-(oxan-4-ylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CCOCC1 UIMBZPRWYBAKNN-STQMWFEESA-N 0.000 claims 1
- OJZREVAFYSJEBS-VYAYZGMFSA-N (2s,5r)-5-ethynyl-1-[2-(oxolan-2-ylmethylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNCC1CCCO1 OJZREVAFYSJEBS-VYAYZGMFSA-N 0.000 claims 1
- YPKDEDQORSVCBF-RAMGSTBQSA-N (2s,5r)-5-ethynyl-1-[2-(oxolan-3-ylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CCOC1 YPKDEDQORSVCBF-RAMGSTBQSA-N 0.000 claims 1
- JCONWQPPNCIKSH-STQMWFEESA-N (2s,5r)-5-ethynyl-1-[2-(piperidin-4-ylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1CCNCC1 JCONWQPPNCIKSH-STQMWFEESA-N 0.000 claims 1
- FGPHPVZAMFRKCX-KBPBESRZSA-N (2s,5r)-5-ethynyl-1-[2-(pyridin-2-ylmethylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNCC1=CC=CC=N1 FGPHPVZAMFRKCX-KBPBESRZSA-N 0.000 claims 1
- AVEDBIVZROIHRS-IRXDYDNUSA-N (2s,5r)-5-ethynyl-1-[2-[(1-pyridin-2-ylpiperidin-4-yl)amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(CC1)CCN1C1=CC=CC=N1 AVEDBIVZROIHRS-IRXDYDNUSA-N 0.000 claims 1
- UALCSJKCLSEBIH-RYUDHWBXSA-N (2s,5r)-5-ethynyl-1-[2-[(3-hydroxy-2,2-dimethylpropyl)amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound OCC(C)(C)CNCC(=O)N1[C@@H](C#C)CC[C@H]1C#N UALCSJKCLSEBIH-RYUDHWBXSA-N 0.000 claims 1
- RJSJVYMTPHMGGA-ILGZHXLLSA-N (2s,5r)-5-ethynyl-1-[2-[(4-hydroxy-1-methylcyclohexyl)amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1(C)CCC(O)CC1 RJSJVYMTPHMGGA-ILGZHXLLSA-N 0.000 claims 1
- FPGIYBPNQHUTFG-GJZGRUSLSA-N (2s,5r)-5-ethynyl-1-[2-[(4-iodophenyl)methylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(I)=CC=C1CNCC(=O)N1[C@H](C#N)CC[C@@H]1C#C FPGIYBPNQHUTFG-GJZGRUSLSA-N 0.000 claims 1
- ZULCHIGDLPHEPE-IRXDYDNUSA-N (2s,5r)-5-ethynyl-1-[2-[(4-methyl-1-pyridin-2-ylpiperidin-4-yl)amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CC=CC=N1 ZULCHIGDLPHEPE-IRXDYDNUSA-N 0.000 claims 1
- RJLGUOCTDWCYPO-RYUDHWBXSA-N (2s,5r)-5-ethynyl-1-[2-[3-(methylamino)propylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CNCCCNCC(=O)N1[C@@H](C#C)CC[C@H]1C#N RJLGUOCTDWCYPO-RYUDHWBXSA-N 0.000 claims 1
- MHILRUWSMSXEGC-XYIZDEMUSA-N (2s,5r)-5-ethynyl-1-[2-[[(2s)-2-hydroxycyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound O[C@H]1CCCC1NCC(=O)N1[C@H](C#N)CC[C@@H]1C#C MHILRUWSMSXEGC-XYIZDEMUSA-N 0.000 claims 1
- FLEJLFCEMOMGJU-KGVIZRLGSA-N (2s,5r)-5-ethynyl-1-[2-[[(5r,7s)-3-hydroxy-1-adamantyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C([C@@](C1)([H])C[C@@](C2)(C3)[H])C2(O)CC31NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N FLEJLFCEMOMGJU-KGVIZRLGSA-N 0.000 claims 1
- UWQNMCCYXHILOT-KBPBESRZSA-N (2s,5r)-5-ethynyl-1-[2-[[1-(2-hydroxypropan-2-yl)cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1(C(C)(O)C)CCCC1 UWQNMCCYXHILOT-KBPBESRZSA-N 0.000 claims 1
- PZHXBQYIQQDZNF-IRXDYDNUSA-N (2s,5r)-5-ethynyl-1-[2-[[1-(4-fluorophenyl)-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)CC1=CC=C(F)C=C1 PZHXBQYIQQDZNF-IRXDYDNUSA-N 0.000 claims 1
- JKHALJALYGUOKY-STQMWFEESA-N (2s,5r)-5-ethynyl-1-[2-[[1-(hydroxymethyl)cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1(CO)CCCC1 JKHALJALYGUOKY-STQMWFEESA-N 0.000 claims 1
- DOOWKXARHBIBJS-KBPBESRZSA-N (2s,5r)-5-ethynyl-1-[2-[[1-(methoxymethyl)cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC1(COC)CCCC1 DOOWKXARHBIBJS-KBPBESRZSA-N 0.000 claims 1
- UCOZFJBTDHDXCE-IRXDYDNUSA-N (2s,5r)-5-ethynyl-1-[2-[[2-methyl-1-(quinolin-4-ylamino)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C=1C=NC2=CC=CC=C2C=1NCC(C)(C)NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N UCOZFJBTDHDXCE-IRXDYDNUSA-N 0.000 claims 1
- ITBDHPHHCXVSCN-GJZGRUSLSA-N (2s,5r)-5-ethynyl-1-[2-[[2-methyl-1-[5-(trifluoromethyl)pyridin-2-yl]oxypropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)COC1=CC=C(C(F)(F)F)C=N1 ITBDHPHHCXVSCN-GJZGRUSLSA-N 0.000 claims 1
- ZOPXQJZSDLRPKC-STQMWFEESA-N (2s,5r)-5-ethynyl-1-[2-[[2-methyl-1-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)CNC1=NC=CC(C(F)(F)F)=N1 ZOPXQJZSDLRPKC-STQMWFEESA-N 0.000 claims 1
- QOZWNOXVGRAMJD-BXRCABCMSA-N (2s,5r)-5-ethynyl-1-[2-[[4-(3-fluorophenoxy)-1-methylcyclohexyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCC1OC1=CC=CC(F)=C1 QOZWNOXVGRAMJD-BXRCABCMSA-N 0.000 claims 1
- IJWUZVSXDWDIEQ-NHUPUQRLSA-N (2s,5r)-5-ethynyl-1-[2-[[4-(4-fluorophenoxy)-1-methylcyclohexyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCC1OC1=CC=C(F)C=C1 IJWUZVSXDWDIEQ-NHUPUQRLSA-N 0.000 claims 1
- RIJBNYOVPPZVQM-IRDVNMAFSA-N (2s,5r)-5-ethynyl-1-[2-[[4-(5-fluoropyridin-3-yl)oxy-1-methylcyclohexyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCC1OC1=CN=CC(F)=C1 RIJBNYOVPPZVQM-IRDVNMAFSA-N 0.000 claims 1
- DTAGXVNPYZDEBD-ROUUACIJSA-N (2s,5r)-5-ethynyl-1-[2-[[4-methyl-1-(pyridine-4-carbonyl)piperidin-4-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C(=O)C1=CC=NC=C1 DTAGXVNPYZDEBD-ROUUACIJSA-N 0.000 claims 1
- GYFPZSRWINACNH-IRXDYDNUSA-N (2s,5r)-5-ethynyl-1-[2-[[4-methyl-1-[4-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CC(C(F)(F)F)=CC=N1 GYFPZSRWINACNH-IRXDYDNUSA-N 0.000 claims 1
- LYXXGPHZEILHRL-GJZGRUSLSA-N (2s,5r)-5-ethynyl-1-[2-[[4-methyl-1-[4-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=NC=CC(C(F)(F)F)=N1 LYXXGPHZEILHRL-GJZGRUSLSA-N 0.000 claims 1
- WMXAIKHXKCGWAM-IRXDYDNUSA-N (2s,5r)-5-ethynyl-1-[2-[[4-methyl-1-[5-(trifluoromethyl)pyridin-2-yl]piperidin-4-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CC=C(C(F)(F)F)C=N1 WMXAIKHXKCGWAM-IRXDYDNUSA-N 0.000 claims 1
- ARQRELUDHZKQQO-JMDAGXMHSA-N (2s,5r)-5-prop-1-ynyl-1-[2-[[4-[4-(trifluoromethyl)phenoxy]cyclohexyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC#C[C@H]1CC[C@@H](C#N)N1C(=O)CNC1CCC(OC=2C=CC(=CC=2)C(F)(F)F)CC1 ARQRELUDHZKQQO-JMDAGXMHSA-N 0.000 claims 1
- PKGKKSBWYVGOCB-IHRRRGAJSA-N (2s,5s)-1-[(2s)-2-amino-2-cyclohexylacetyl]-5-ethylpyrrolidine-2-carbonitrile Chemical compound CC[C@H]1CC[C@@H](C#N)N1C(=O)[C@@H](N)C1CCCCC1 PKGKKSBWYVGOCB-IHRRRGAJSA-N 0.000 claims 1
- MRERLGSGIBCVRW-DLOVCJGASA-N (2s,5s)-1-[(2s)-2-amino-2-cyclopentylacetyl]-5-methylpyrrolidine-2-carbonitrile Chemical compound C[C@H]1CC[C@@H](C#N)N1C(=O)[C@@H](N)C1CCCC1 MRERLGSGIBCVRW-DLOVCJGASA-N 0.000 claims 1
- VDXJFUZPHJSXLI-CIUDSAMLSA-N (2s,5s)-1-[(2s)-2-amino-3-methylbutanoyl]-4,4-difluoro-5-methylpyrrolidine-2-carbonitrile Chemical compound CC(C)[C@H](N)C(=O)N1[C@@H](C)C(F)(F)C[C@H]1C#N VDXJFUZPHJSXLI-CIUDSAMLSA-N 0.000 claims 1
- HONCDBWOECPCCV-GUBZILKMSA-N (2s,5s)-1-[(2s)-2-amino-4-methylpentanoyl]-4,4-difluoro-5-methylpyrrolidine-2-carbonitrile Chemical compound CC(C)C[C@H](N)C(=O)N1[C@@H](C)C(F)(F)C[C@H]1C#N HONCDBWOECPCCV-GUBZILKMSA-N 0.000 claims 1
- XAPWGIWPMYCPRT-DCAQKATOSA-N (2s,5s)-1-[(2s)-2-amino-4-methylpentanoyl]-5-methylpyrrolidine-2-carbonitrile Chemical compound CC(C)C[C@H](N)C(=O)N1[C@@H](C)CC[C@H]1C#N XAPWGIWPMYCPRT-DCAQKATOSA-N 0.000 claims 1
- GSVYWUKPDSZURO-JQWIXIFHSA-N (2s,5s)-1-[2-(cyclopentylamino)acetyl]-5-methylpyrrolidine-2-carbonitrile Chemical compound C[C@H]1CC[C@@H](C#N)N1C(=O)CNC1CCCC1 GSVYWUKPDSZURO-JQWIXIFHSA-N 0.000 claims 1
- BDTCWWARUHWSLN-UWVGGRQHSA-N (2s,5s)-1-[2-(tert-butylamino)acetyl]-5-methylpyrrolidine-2-carbonitrile Chemical compound C[C@H]1CC[C@@H](C#N)N1C(=O)CNC(C)(C)C BDTCWWARUHWSLN-UWVGGRQHSA-N 0.000 claims 1
- KXZNKCVRBRNEQU-ZFWWWQNUSA-N (2s,5s)-1-[2-[2-(3,4-dimethoxyphenyl)ethylamino]acetyl]-5-methylpyrrolidine-2-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCNCC(=O)N1[C@H](C#N)CC[C@@H]1C KXZNKCVRBRNEQU-ZFWWWQNUSA-N 0.000 claims 1
- ZTFHMDZAETUKGK-SSUCVIGASA-N (2s,5s)-1-[2-[[(5r,7s)-3-hydroxy-1-adamantyl]amino]acetyl]-5-methylpyrrolidine-2-carbonitrile Chemical compound C([C@@](C1)([H])C[C@@](C2)(C3)[H])C2(O)CC31NCC(=O)N1[C@@H](C)CC[C@H]1C#N ZTFHMDZAETUKGK-SSUCVIGASA-N 0.000 claims 1
- SYEVCPQPZCDCAL-RYUDHWBXSA-N (2s,5s)-1-[2-[[1-(hydroxymethyl)cyclopentyl]amino]acetyl]-5-methylpyrrolidine-2-carbonitrile Chemical compound C[C@H]1CC[C@@H](C#N)N1C(=O)CNC1(CO)CCCC1 SYEVCPQPZCDCAL-RYUDHWBXSA-N 0.000 claims 1
- SHZUMCDMFANEEL-CQDKDKBSSA-N (2s,5s)-5-methyl-1-[(3s)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl]pyrrolidine-2-carbonitrile Chemical compound C[C@H]1CC[C@@H](C#N)N1C(=O)[C@H]1NCC2=CC=CC=C2C1 SHZUMCDMFANEEL-CQDKDKBSSA-N 0.000 claims 1
- NQXBVVRUCOALGO-UWVGGRQHSA-N (2s,5s)-5-methyl-1-[2-(propan-2-ylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound CC(C)NCC(=O)N1[C@@H](C)CC[C@H]1C#N NQXBVVRUCOALGO-UWVGGRQHSA-N 0.000 claims 1
- JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 claims 1
- GDMADLFBTPKPSM-IRXDYDNUSA-N 2-[2-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropoxy]-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(OCC(C)(C)NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)=N1 GDMADLFBTPKPSM-IRXDYDNUSA-N 0.000 claims 1
- SVWBRDYRQDYEMN-ROUUACIJSA-N 2-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-4-methylpiperidin-1-yl]pyridine-3-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=NC=CC=C1C#N SVWBRDYRQDYEMN-ROUUACIJSA-N 0.000 claims 1
- FIMRNLAKAARHPD-IRXDYDNUSA-N 2-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-4-methylpiperidin-1-yl]pyridine-4-carboxylic acid Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CC(C(O)=O)=CC=N1 FIMRNLAKAARHPD-IRXDYDNUSA-N 0.000 claims 1
- BLZAGFMIBKLPJZ-IRXDYDNUSA-N 2-[[2-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]amino]-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(NCC(C)(C)NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)=N1 BLZAGFMIBKLPJZ-IRXDYDNUSA-N 0.000 claims 1
- TVYLZOIGVQTSGW-HOTGVXAUSA-N 2-[[2-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]amino]pyridine-3-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)CNC1=NC=CC=C1C#N TVYLZOIGVQTSGW-HOTGVXAUSA-N 0.000 claims 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 1
- CMAVFJLWDXFZIP-IJXZTRCJSA-N 3-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]piperidin-1-yl]-2h-pyridine-3-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(CC1)CCN1C1(C#N)CN=CC=C1 CMAVFJLWDXFZIP-IJXZTRCJSA-N 0.000 claims 1
- BDQKITMXKJRLFS-IRXDYDNUSA-N 4-[[2-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]amino]benzoic acid Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)CNC1=CC=C(C(O)=O)C=C1 BDQKITMXKJRLFS-IRXDYDNUSA-N 0.000 claims 1
- NIOATAOKNBTQHP-ROUUACIJSA-N 5-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-4-methylpiperidin-1-yl]pyridine-3-carbonitrile Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CN=CC(C#N)=C1 NIOATAOKNBTQHP-ROUUACIJSA-N 0.000 claims 1
- BRNJVOMUXOANTQ-RYUDHWBXSA-N 5-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]pentanoic acid Chemical compound OC(=O)CCCCNCC(=O)N1[C@@H](C#C)CC[C@H]1C#N BRNJVOMUXOANTQ-RYUDHWBXSA-N 0.000 claims 1
- XIXIIEJGKJGAJP-HOTGVXAUSA-N 6-[2-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropoxy]pyridine-3-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)COC1=CC=C(C#N)C=N1 XIXIIEJGKJGAJP-HOTGVXAUSA-N 0.000 claims 1
- SBUQZWWZUYXHKO-JSGCOSHPSA-N 6-[2-[[2-[(2s,5s)-2-cyano-5-methylpyrrolidin-1-yl]-2-oxoethyl]amino]ethylamino]pyridine-3-carbonitrile Chemical compound C[C@H]1CC[C@@H](C#N)N1C(=O)CNCCNC1=CC=C(C#N)C=N1 SBUQZWWZUYXHKO-JSGCOSHPSA-N 0.000 claims 1
- FRCBKXRKIDHEMG-IRXDYDNUSA-N 6-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-4-methylpiperidin-1-yl]pyridine-3-carboxylic acid Chemical compound C1CC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CCN1C1=CC=C(C(O)=O)C=N1 FRCBKXRKIDHEMG-IRXDYDNUSA-N 0.000 claims 1
- CBFPTXDGNGGMLX-YBXZHIRMSA-N 6-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]cyclohexyl]oxypyridine-3-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(CC1)CCC1OC1=CC=C(C#N)C=N1 CBFPTXDGNGGMLX-YBXZHIRMSA-N 0.000 claims 1
- RZMKZEFDKCFQQN-ROUUACIJSA-N 6-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]piperidin-1-yl]pyridine-3-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(CC1)CCN1C1=CC=C(C#N)C=N1 RZMKZEFDKCFQQN-ROUUACIJSA-N 0.000 claims 1
- OPCHPSUHKICLLJ-HOTGVXAUSA-N 6-[[2-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]amino]pyridine-3-carbonitrile Chemical compound N1([C@@H](CC[C@@H]1C#C)C#N)C(=O)CNC(C)(C)CNC1=CC=C(C#N)C=N1 OPCHPSUHKICLLJ-HOTGVXAUSA-N 0.000 claims 1
- XJWCLEICCCQHCI-WRMIUGFKSA-N C([C@]1(CC2C[C@@](C3)(C1)[H])[H])C23NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N Chemical compound C([C@]1(CC2C[C@@](C3)(C1)[H])[H])C23NCC(=O)N1[C@@H](C#C)CC[C@H]1C#N XJWCLEICCCQHCI-WRMIUGFKSA-N 0.000 claims 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- 125000005093 alkyl carbonyl alkyl group Chemical group 0.000 claims 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000003725 azepanyl group Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000004069 aziridinyl group Chemical group 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 1
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 claims 1
- 125000000532 dioxanyl group Chemical group 0.000 claims 1
- 125000005883 dithianyl group Chemical group 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000000262 haloalkenyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 claims 1
- 201000008980 hyperinsulinism Diseases 0.000 claims 1
- 125000002632 imidazolidinyl group Chemical group 0.000 claims 1
- 125000002636 imidazolinyl group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 claims 1
- 125000005969 isothiazolinyl group Chemical group 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 claims 1
- 125000003971 isoxazolinyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- KXRWWPBGASDSIL-PMACEKPBSA-N methyl 4-[4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-4-methylpiperidine-1-carbonyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C(=O)N1CCC(C)(NCC(=O)N2[C@@H](CC[C@@H]2C#C)C#N)CC1 KXRWWPBGASDSIL-PMACEKPBSA-N 0.000 claims 1
- OVBGPPQGSDXWQS-HOTGVXAUSA-N methyl 6-[[2-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]amino]pyridine-3-carboxylate Chemical compound N1=CC(C(=O)OC)=CC=C1NCC(C)(C)NCC(=O)N1[C@H](C#N)CC[C@@H]1C#C OVBGPPQGSDXWQS-HOTGVXAUSA-N 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 125000005963 oxadiazolidinyl group Chemical group 0.000 claims 1
- 125000005882 oxadiazolinyl group Chemical group 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000000160 oxazolidinyl group Chemical group 0.000 claims 1
- 125000005968 oxazolinyl group Chemical group 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims 1
- 125000002755 pyrazolinyl group Chemical group 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000001422 pyrrolinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- QGFZCKNMIUQRMV-HOTGVXAUSA-N tert-butyl 4-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NCC(=O)N1[C@H](C#N)CC[C@@H]1C#C QGFZCKNMIUQRMV-HOTGVXAUSA-N 0.000 claims 1
- KPHTXKPRTZEPAH-IRXDYDNUSA-N tert-butyl 4-[[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CNCC(=O)N1[C@H](C#N)CC[C@@H]1C#C KPHTXKPRTZEPAH-IRXDYDNUSA-N 0.000 claims 1
- JRGSPEXUHUHERV-GJZGRUSLSA-N tert-butyl 5-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]pentanoate Chemical compound CC(C)(C)OC(=O)CCCCNCC(=O)N1[C@@H](C#C)CC[C@H]1C#N JRGSPEXUHUHERV-GJZGRUSLSA-N 0.000 claims 1
- ZRTUOVSACIWZRA-GJZGRUSLSA-N tert-butyl n-[3-[[2-[(2s,5r)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]propyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CCCNCC(=O)N1[C@@H](C#C)CC[C@H]1C#N ZRTUOVSACIWZRA-GJZGRUSLSA-N 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 1
- 125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000005304 thiadiazolidinyl group Chemical group 0.000 claims 1
- 125000005305 thiadiazolinyl group Chemical group 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000001984 thiazolidinyl group Chemical group 0.000 claims 1
- 125000002769 thiazolinyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
- 125000004306 triazinyl group Chemical group 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- 125000005455 trithianyl group Chemical group 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24683102A | 2002-09-19 | 2002-09-19 | |
| US10/246,831 | 2002-09-19 | ||
| US10/659,860 US20040121964A1 (en) | 2002-09-19 | 2003-09-11 | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| US10/659,860 | 2003-09-11 | ||
| PCT/US2003/029018 WO2004026822A2 (en) | 2002-09-19 | 2003-09-15 | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006503057A JP2006503057A (ja) | 2006-01-26 |
| JP2006503057A5 true JP2006503057A5 (OSRAM) | 2006-10-19 |
| JP4712387B2 JP4712387B2 (ja) | 2011-06-29 |
Family
ID=32033228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004537831A Expired - Fee Related JP4712387B2 (ja) | 2002-09-19 | 2003-09-15 | ジペプチジルペプチダーゼ−ｉｖ（ｄｐｐ−ｉｖ）阻害薬としての医薬組成物 |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1560811B9 (OSRAM) |
| JP (1) | JP4712387B2 (OSRAM) |
| KR (1) | KR101072236B1 (OSRAM) |
| CN (1) | CN101676264A (OSRAM) |
| AT (1) | ATE368647T1 (OSRAM) |
| AU (1) | AU2003282800B2 (OSRAM) |
| BR (1) | BR0314582A (OSRAM) |
| CA (2) | CA2768674A1 (OSRAM) |
| CY (1) | CY1110361T1 (OSRAM) |
| DE (1) | DE60315336T2 (OSRAM) |
| DK (1) | DK1560811T3 (OSRAM) |
| ES (1) | ES2290511T3 (OSRAM) |
| IL (1) | IL167434A (OSRAM) |
| MX (1) | MXPA05003091A (OSRAM) |
| NZ (1) | NZ538567A (OSRAM) |
| PL (1) | PL374732A1 (OSRAM) |
| PT (1) | PT1560811E (OSRAM) |
| TW (1) | TWI320406B (OSRAM) |
| WO (1) | WO2004026822A2 (OSRAM) |
| ZA (1) | ZA200502218B (OSRAM) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050122220A (ko) | 2003-03-25 | 2005-12-28 | 다케다 샌디에고, 인코포레이티드 | 디펩티딜 펩티다제 억제제 |
| WO2004098591A2 (en) | 2003-05-05 | 2004-11-18 | Probiodrug Ag | Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| EP1625122A1 (en) | 2003-05-14 | 2006-02-15 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| KR20060041309A (ko) | 2003-08-13 | 2006-05-11 | 다케다 야쿠힌 고교 가부시키가이샤 | ４-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도 |
| US7205409B2 (en) | 2003-09-04 | 2007-04-17 | Abbott Laboratories | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| WO2005023762A1 (en) * | 2003-09-04 | 2005-03-17 | Abbott Laboratories | Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| WO2005073186A1 (ja) * | 2004-01-29 | 2005-08-11 | Ono Pharmaceutical Co., Ltd. | ピロリジン誘導体 |
| CA2554493C (en) | 2004-02-05 | 2012-06-26 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| WO2005095339A1 (en) * | 2004-03-31 | 2005-10-13 | Pfizer Products Inc. | Dicyanopyrrolidines as dipeptidyl peptidase iv inhibitors |
| EP1756106A4 (en) * | 2004-05-18 | 2008-12-17 | Merck & Co Inc | CYCLOHEXYLALANINE DERIVATIVES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES |
| WO2006006065A1 (en) * | 2004-07-08 | 2006-01-19 | Warner-Lambert Company Llc | Androgen modulators |
| EP1794120B1 (en) * | 2004-07-23 | 2012-04-11 | Nuada, LLC | Peptidase inhibitors |
| WO2006011035A1 (en) * | 2004-07-23 | 2006-02-02 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
| AP2007003973A0 (en) | 2004-10-12 | 2007-07-30 | Glenmark Pharmaceuticals Sa | Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation |
| JP2008019168A (ja) * | 2004-10-22 | 2008-01-31 | Astellas Pharma Inc | ２−シアノ−４−フルオロピロリジン誘導体の製造法 |
| WO2006118196A1 (ja) * | 2005-04-27 | 2006-11-09 | Ajinomoto Co., Inc. | Dpp4阻害剤及びその医薬用途 |
| US20080300251A1 (en) * | 2005-09-05 | 2008-12-04 | Sattigeri Jitendra A | Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors |
| PT1942898E (pt) | 2005-09-14 | 2011-12-20 | Takeda Pharmaceutical | Inibidores da dipeptidilpeptidase para o tratamento da diabetes |
| CN101360723A (zh) | 2005-09-16 | 2009-02-04 | 武田药品工业株式会社 | 制备嘧啶二酮衍生物的方法 |
| GB0526291D0 (en) | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
| CN101395131B (zh) | 2006-03-08 | 2012-11-14 | 杏林制药株式会社 | 氨基乙酰基吡咯烷甲腈衍生物的制备方法及其制备中间体 |
| WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| AU2007232311B2 (en) * | 2006-04-03 | 2012-08-09 | Mylan Laboratories Ltd | Novel dipeptidyl peptidase IV inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| CA2649209A1 (en) | 2006-04-12 | 2007-10-18 | Probiodrug Ag | Enzyme inhibitors |
| CA2657930A1 (en) * | 2006-07-20 | 2008-01-24 | Abbott Laboratories | Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| JPWO2008114857A1 (ja) | 2007-03-22 | 2010-07-08 | 杏林製薬株式会社 | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| GB2465132B (en) | 2007-09-21 | 2012-06-06 | Lupin Ltd | Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors |
| EP2322499A4 (en) | 2008-08-07 | 2011-12-21 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING A BICYCLO [2,2,2] OCTYLAMINE DERIVATIVE |
| WO2010146597A1 (en) | 2009-06-18 | 2010-12-23 | Lupin Limited | 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors |
| AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
| CA2772488C (en) | 2009-09-11 | 2018-04-17 | Probiodrug Ag | Heterocyclic derivatives as inhibitors of glutaminyl cyclase |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| JP5764148B2 (ja) * | 2010-03-10 | 2015-08-12 | ヤンセン ファーマシューティカ エヌ．ベー． | ジペプチジルペプチダーゼ−１（ｄｐｐ−１）の阻害剤として有用な４，４−二置換されたピペリジン誘導体 |
| NZ602312A (en) | 2010-03-10 | 2014-02-28 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| JP2013523819A (ja) | 2010-04-06 | 2013-06-17 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Ｇｐｒ１１９レセプターのモジュレーターおよびそれに関連する障害の処置 |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| TWI403716B (zh) * | 2010-08-13 | 2013-08-01 | Nat Univ Tsing Hua | 氫氣檢測器、系統及方法 |
| PH12013500547A1 (en) | 2010-09-22 | 2013-06-10 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| TWI500613B (zh) | 2012-10-17 | 2015-09-21 | Cadila Healthcare Ltd | 新穎之雜環化合物 |
| WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
| CN105399700A (zh) * | 2013-01-06 | 2016-03-16 | 天津市汉康医药生物技术有限公司 | 噻唑烷衍生物、其制备方法和用途 |
| JP6590226B2 (ja) * | 2016-05-11 | 2019-10-16 | 株式会社シード探索研究所 | オキサアジリジン化合物およびその製造方法 |
| WO2018049014A1 (en) | 2016-09-07 | 2018-03-15 | Trustees Of Tufts College | Dash inhibitors, and uses related thereto |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| CN114213504B (zh) * | 2021-12-24 | 2023-05-09 | 西南医科大学 | 一类具有抗糖尿病活性的化合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
| US5691356A (en) * | 1994-03-21 | 1997-11-25 | Bristol-Myers Squibb Company | Disubstituted heterocyclic thrombin inhibitors |
| CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| US6172081B1 (en) | 1999-06-24 | 2001-01-09 | Novartis Ag | Tetrahydroisoquinoline 3-carboxamide derivatives |
| TW583185B (en) * | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
-
2003
- 2003-09-15 JP JP2004537831A patent/JP4712387B2/ja not_active Expired - Fee Related
- 2003-09-15 CN CN200910166852A patent/CN101676264A/zh active Pending
- 2003-09-15 CA CA2768674A patent/CA2768674A1/en not_active Abandoned
- 2003-09-15 KR KR1020057004773A patent/KR101072236B1/ko not_active Expired - Fee Related
- 2003-09-15 EP EP03774478A patent/EP1560811B9/en not_active Expired - Lifetime
- 2003-09-15 BR BR0314582-4A patent/BR0314582A/pt not_active IP Right Cessation
- 2003-09-15 CA CA2497725A patent/CA2497725C/en not_active Expired - Fee Related
- 2003-09-15 PT PT03774478T patent/PT1560811E/pt unknown
- 2003-09-15 NZ NZ538567A patent/NZ538567A/en not_active IP Right Cessation
- 2003-09-15 AT AT03774478T patent/ATE368647T1/de active
- 2003-09-15 AU AU2003282800A patent/AU2003282800B2/en not_active Ceased
- 2003-09-15 WO PCT/US2003/029018 patent/WO2004026822A2/en not_active Ceased
- 2003-09-15 MX MXPA05003091A patent/MXPA05003091A/es active IP Right Grant
- 2003-09-15 DK DK03774478T patent/DK1560811T3/da active
- 2003-09-15 DE DE60315336T patent/DE60315336T2/de not_active Expired - Lifetime
- 2003-09-15 ES ES03774478T patent/ES2290511T3/es not_active Expired - Lifetime
- 2003-09-15 PL PL03374732A patent/PL374732A1/xx unknown
- 2003-09-19 TW TW092125921A patent/TWI320406B/zh not_active IP Right Cessation
-
2005
- 2005-02-16 ZA ZA2005/02218A patent/ZA200502218B/en unknown
- 2005-03-15 IL IL167434A patent/IL167434A/en not_active IP Right Cessation
-
2007
- 2007-10-23 CY CY20071101364T patent/CY1110361T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006503057A5 (OSRAM) | ||
| CA2497725A1 (en) | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) | |
| RU2454405C2 (ru) | Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина | |
| RU2404164C2 (ru) | Производные пиридин-3-карбоксамида в качестве обратных агонистов св1 | |
| RU2455288C2 (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| CA2575073A1 (en) | Fungicidal composition containing acid amide derivative | |
| TWI377910B (en) | Hydrazide compound and pesticidal use of the same | |
| JP2016523925A5 (OSRAM) | ||
| JP2005514334A5 (OSRAM) | ||
| JP2006500369A5 (OSRAM) | ||
| CA2400261A1 (en) | Phenacylamine derivatives, process for their production and pesticides containing them | |
| CA2550596A1 (en) | 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors | |
| JP2012510989A5 (OSRAM) | ||
| JP2018509418A5 (OSRAM) | ||
| HRP20190728T1 (hr) | Derivati aminobenzamida kao učinkovita sredstva za kontrolu životinjskih parazita | |
| WO2011042797A4 (en) | Pyrazole derivatives as modulators of calcium release -activated calcium channel | |
| JP2002080453A5 (OSRAM) | ||
| JP2007530459A5 (OSRAM) | ||
| AR078619A1 (es) | Derivados de ciclohexano espiro-condensados como inhibidores de hsl, utiles en el tratamiento de la diabetes | |
| JP2014511869A5 (OSRAM) | ||
| JP2006516145A5 (OSRAM) | ||
| JP2017538785A5 (OSRAM) | ||
| NO20052995L (no) | 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer. | |
| NZ588652A (en) | Carboxamide compounds for the treatment of metabolic disorders | |
| CA2644425A1 (en) | Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |